Moderna, Inc. (NASDAQ:MRNA) | Finanzwire

Basculer en Français

9904	Companies
199560	Keywords
130428	Articles
106065	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 02/14/2025 at 12:28, 1 year ago

Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
Moderna, Inc. reports Q4 revenues of $1.0B with a net loss of $(1.1)B. Forecasts 2025 revenue of $1.5-2.5B. Submitted 3 mRNA products for regulatory approval. Financial details and pipeline updates disclosed

Revenues Net Loss Moderna MRNA Products 2025 Revenue
BRIEF

published on 01/29/2025 at 13:05, 1 year ago

Moderna to Announce Financial Results for Q4 and 2024

Financial Results Webcast Corporate Update MRNA Technology Moderna
PRESS RELEASE

published on 01/29/2025 at 13:00, 1 year ago

Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025
Moderna, Inc. to host conference call on February 14, 2025 to report Q4 and full year 2024 financial results, and provide a corporate update. Details on webcast available on Moderna website

Financial Results Conference Call Webcast Moderna Inc. MRNA Medicine
BRIEF

published on 01/24/2025 at 12:35, 1 year ago

Moderna Secures EU Tender for mRNA COVID-19 Vaccine Supply

COVID-19 Moderna MRNA Vaccine Spikevax EU Tender
PRESS RELEASE

published on 01/24/2025 at 12:30, 1 year ago

Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
Moderna awarded tender to supply mRNA COVID-19 vaccine in EU, Norway, and North Macedonia, offering diverse formats like prefilled syringes. Enhancing vaccination campaigns with efficient options

COVID-19 Moderna MRNA Vaccine Vaccination Campaigns Prefilled Syringes
BRIEF

published on 01/17/2025 at 22:33, 1 year 1 month ago

Moderna Advances mRNA-Based Influenza Vaccine Development

Clinical Trials Moderna MRNA Vaccines BARDA Funding Influenza
PRESS RELEASE

published on 01/17/2025 at 22:28, 1 year 1 month ago

Moderna Announces Updates on Pandemic Influenza Program
Moderna announces ongoing support from HHS to accelerate mRNA-based pandemic influenza vaccines development. Award received through BARDA-funded RRPV Consortium

Moderna MRNA BARDA HHS Pandemic Influenza Vaccines
BRIEF

published on 01/13/2025 at 13:05, 1 year 1 month ago

Moderna Outlines Strategic Moves at J.P. Morgan Healthcare Conference

Cost Reduction Plan Vaccine Approvals Moderna Financials 2025 Revenue Forecast Pipeline Milestones
PRESS RELEASE

published on 01/13/2025 at 13:00, 1 year 1 month ago

Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
Moderna, Inc. announces 2024 financial achievements and 2025 projections with emphasis on revenue growth, cost reductions, and pipeline milestones including COVID-19 and flu vaccines

Revenue Growth Financial Updates Moderna Cost Reductions Pipeline Milestones
BRIEF

published on 11/25/2024 at 13:05, 1 year 2 months ago

Moderna to Present at December 2024 Investor Conferences

Investor Conferences Healthcare Webcast MRNA Technology Moderna

Accesswire

Published on 02/21/2026 at 00:45, 1 day 8 hours ago

Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 1 day 8 hours ago

Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:15, 1 day 10 hours ago

DigiPower X Announces Closing of Settlement
Published on 02/20/2026 at 23:00, 1 day 10 hours ago

Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 1 day 11 hours ago

Organto Foods Completes Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 02/21/2026 at 12:00, 21 hours 21 minutes ago

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/20/2026 at 18:36, 1 day 14 hours ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 1 day 14 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:23, 1 day 14 hours ago

POS-Transaction in Own Shares
Published on 02/20/2026 at 18:00, 1 day 15 hours ago

Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

Les Echos

Published on 02/20/2026 at 19:29, 1 day 13 hours ago

SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 18:00, 1 day 15 hours ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 09:28, 1 day 23 hours ago

Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
Published on 02/20/2026 at 07:30, 2 days 1 hour ago

Announcement of share buyback in the context of a share purchase plan
Published on 02/20/2026 at 07:30, 2 days 1 hour ago

EURAZEO COMPLETES THE SALE OF EX NIHILO TO L CATTERTON

View all LES ECHOS COMFI WIRE